Fulcrum Therapeutics Total Risk Alpha
Total Risk Alpha measures the excess return of an asset after comparing its performance to a benchmark portfolio matched to the same total risk level. Unlike Jensen Alpha, which adjusts for systematic risk (beta) only, Total Risk Alpha accounts for total volatility. Below is Fulcrum Therapeutics's current Total Risk Alpha with peer comparisons and related risk metrics.
Current Total Risk Alpha Value
At 0, Fulcrum Therapeutics's Total Risk Alpha indicates slightly negative alpha — return marginally below the CAPM-predicted level. Fulcrum Therapeutics has slightly underperformed relative to what its market beta would imply.
| = | 0 |
| ER[a] | = | Expected return on investing in Fulcrum Therapeutics |
| ER[b] | = | Expected return on market index or selected benchmark |
| STD[a] | = | Standard Deviation of returns on Fulcrum Therapeutics |
| STD[b] | = | Standard Deviation of selected market or benchmark |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
Total Risk Alpha Peers Comparison
Total Risk Alpha Relative To Other Indicators
The chart below plots Total Risk Alpha against Maximum Drawdown for Fulcrum Therapeutics and its peers. Each point represents one equity — position along the horizontal axis shows Total Risk Alpha while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
Total Risk Alpha |
Maximum Drawdown |
Methodology, Assumptions & Data Sources
Fulcrum Therapeutics has a current Total Risk Alpha reading of 0. This Total Risk Alpha reading for Fulcrum Therapeutics results from applying the indicator's calculation rules to price and volume data over the selected window. Price data is sourced from standardized end-of-day feeds across supported exchanges, normalized for corporate actions. Indicator accuracy depends on data continuity across the calculation period. Gaps in trading history may affect the output.